In a recent report, the Elders of the Court of Auditors recommend the generalization of the pharmaceutical file set up in 2007 and managed by the National Council of the Order of Pharmacists (CNOP).
The Court of Auditors calls for the generalization of the pharmaceutical file (DP) and congratulates the National Council of the Order of Pharmacists (CNOP) for its management, which was entrusted to it as soon as it was set up.
A productive precautionary measure
Created by the law of January 30, 2007 relating to the organization of certain health professions, the DP identifies, for each beneficiary of the Health Insurance who so wishes, all the drugs that have been issued to him during the last four months. The primary objective of this is to facilitate coordination between healthcare professionals and to secure the distribution of medicines, in particular for patients with chronic illnesses and/or who are changing pharmacies.
However, the advantages have exceeded the expectations of pharmacists, since it also promotes vaccination coverage, makes it possible to avoid redundant treatments, to detect risks of interactions between drugs, to better coordinate care between the city and hospitals, contributes to the correct dosage of the drug and has the most recent information possible. It also allows to anticipate possible shortages of medicines, withdrawals or health alerts. In 2011, 334 reminders were made using this system.
In 2018, 60% of French people had an active PD, according to Le Figarothe elderly and young children being the most affected. Noting that he “does not yet cover the entire French population”the Sages consider that “the creation of a file should become automatic unless the user objects.”
Duration and respect of personal data
To improve the system, the Court of Auditors nevertheless recommends increasing the period of 4 months during which the patient’s information can be consulted and believes that its generalization will have to be done “by guaranteeing its articulation with the shared medical file and the digital health space”. According to her, this is a “priority” subject for the future.
Similarly, the Elders believe that the CNOP still needs to work to “consolidate” respect for patients’ personal data. It will be necessary “complete the compliance of the pharmaceutical dossier with the general regulations on the protection of personal data by 2021 at the latest (GDPR), in particular the performance of privacy impact studies.”
